Oct 2026· Iran Journal of Computer Science· Vol 9· 0 citations· 41 references
Computational Drug Discovery Methods
TL;DR
This study proposes a new approach termed the Multi-Strategy Message Passing Graph Neural Network (MS-MPGN), which combines two complementary strategies: one that maps the overall shape of a molecule and another that focuses on local chemical interactions.
Accurate prediction of cancer drug response is essential for advancing precision oncology; however, existing deep learning approaches, particularly graph neural networks (GNNs), often rely on computationally intensive architectures and lack interpretability, limiting their applicability in real-world clinical settings....
A. Rangesh, G. Devika· International Conference on...· 0 citations
Motivation Predicting drug sensitivity across diverse cancer samples is a fundamental challenge in personalized therapy and drug discovery. This task requires comprehensive characterization of both drug and cancer cell line features. Current approaches often fail to fully capture the complex structural characteristics...
Ren Qi, Shu-Jia Liu, Tian-Hong Quan et al.· PLoS Computational Biology· 0 citations
Identifying and understanding multi-type drug-drug interactions and their associated toxicities is crucial for preventing adverse outcomes, especially in vulnerable populations, such as cancer patients, who may already have compromised health statuses. This paper provides a benchmark study that compares various commonl...
Marios Vottas, Konstantinos Bougiatiotis, Fotis Aisopos et al.· Artificial Intelligence in M...· 0 citations
Drug repurposing and target discovery offer critical strategies for advancing therapeutic development by uncovering the potential biological pathways and novel associations among drugs, genes, and diseases. However, experimental discovery remains expensive and time-consuming, which limits the scalability of large-scale...
Hong-Sheng Xie, Yuan Gao, S. Ke et al.· bioRxiv· 0 citations
This review investigates recent advances in machine learning (ML) for drug repurposing, with applications spanning COVID-19, Parkinson's disease, and cancer. We provide a methodological taxonomy of ML techniques including supervised learning (e.g., random forests, SVMs), unsupervised clustering and dimensionality reduc...
Betel Gurara, Saron Gebremichael, Hana Sheto et al.· IEEE journal of biomedical a...· 0 citations
Machine-learning networks can learn without detailed instructions from a designer. Those that do may offer insight into how the brain reorganizes itself during learning.
MIT News · Artificial Intelligence· news.mit.eduJul 15, 2026
Assistant Professor Pat Pataranutaporn describes a new interface that lets everyday users glimpse inside an AI's neural network before their chatbot ever says a word.
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.